Ted Lystig

Affiliations

From the National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London (J.D.G., M.F.); the Medical University of South Carolina, Charleston, SC (D.P.J.); Tuscan Regional Amyloidosis Centre, Careggi University Hospital, Florence (F.C.), and the Amyloidosis Research and Treatment Center, IRCCS Fondazione Policlinico San Matteo, Pavia (L.O.) - both in Italy; the Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Centro de Investigacíon Biomédica en Red Enfermedades Cardiovaculares, and Centro Nacional de Investigaciones Cardiovasculares (P.G.-P.) - both in Madrid; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart, Amsterdam (P.G.-P.); the Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Eastern Health Clinical School, Box Hill, VIC, Australia (S.G.); the Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (M.G.); the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (M.H.); the Sylvester Comprehensive Cancer Center, University of Miami, Miami (J.H.), and the Amyloidosis Program, Department of Transplant, Mayo Clinic, Jacksonville (J.N.-N.) - both in Florida; the Cardiac Amyloidosis Program, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (A.M.); the Cardiac Amyloidosis Program, Division of Cardiology, Columbia College of Physicians and Surgeons, New York (M.S.M.); the Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (S.H.P.); Duke Clinical Research Institute (F.R., J.G., K.C., H.X.) and Duke University Medical Center (F.R.) - both in Durham, NC; the Pauley Heart Center, Virginia Commonwealth University, Richmond (K.B.S.); the Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh (P.S.); and Eidos Therapeutics affiliate of BridgeBio Pharma, San Francisco (X.C., T.L., U.S., J.C.F.).

Publications (2)

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.

The New England journal of medicine

Avec: Julian D Gillmore , Daniel P Judge , Francesco Cappelli , Marianna Fontana , Pablo Garcia-Pavia , Simon Gibbs , Martha Grogan , Mazen Hanna , James Hoffman , Ahmad Masri , Mathew S Maurer , Jose Nativi-Nicolau , Laura Obici , Steen Hvitfeldt Poulsen , Frank Rockhold , Keyur B Shah , Prem Soman , Jyotsna Garg , Karen Chiswell , Haolin Xu , Xiaofan Cao , Ted Lystig , Uma Sinha , Jonathan C Fox , Auteur inconnu

Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative.

Therapeutic innovation & regulatory science

Avec: J Stephen Mikita , Jules Mitchel , Nicolle M Gatto , John Laschinger , James E Tcheng , Emily P Zeitler , Arlene S Swern , E Dawn Flick , Christopher Dowd , Theodore Lystig , Sara B Calvert

Réseau de co-auteurs

Julian D Gillmore 1 collaboration

Daniel P Judge 1 collaboration

Francesco Cappelli 1 collaboration

Marianna Fontana 1 collaboration

Pablo Garcia-Pavia 1 collaboration

Simon Gibbs 1 collaboration

Martha Grogan 1 collaboration

Mazen Hanna 1 collaboration

James Hoffman 1 collaboration

Ahmad Masri 1 collaboration

Mathew S Maurer 1 collaboration

Jose Nativi-Nicolau 1 collaboration

Laura Obici 1 collaboration

Steen Hvitfeldt Poulsen 1 collaboration

Frank Rockhold 1 collaboration

Keyur B Shah 1 collaboration

Prem Soman 1 collaboration

Jyotsna Garg 1 collaboration

Karen Chiswell 1 collaboration

Haolin Xu 1 collaboration

Xiaofan Cao 1 collaboration

Uma Sinha 1 collaboration

Jonathan C Fox 1 collaboration

None None 1 collaboration

J Stephen Mikita 1 collaboration

Jules Mitchel 1 collaboration

Nicolle M Gatto 1 collaboration

John Laschinger 1 collaboration

James E Tcheng 1 collaboration

Emily P Zeitler 1 collaboration

Arlene S Swern 1 collaboration

E Dawn Flick 1 collaboration

Christopher Dowd 1 collaboration

Theodore Lystig 1 collaboration

Sara B Calvert 1 collaboration